What if you invested $1000 in ABT on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Historical Annual Returns
Over the past 20 years, Abbott Laboratories has delivered an average annual return of 13.7%. The stock peaked in 2017 with a massive +49.5% gain, while investors faced a downturn in 2022 (-19.7%). Overall, the stock finished in the green 16 times out of 20 years.
Avg Return
+13.7%
Win Rate
80%
16W - 4L
Best
+49.5%
2017
Worst
-19.7%
2022
Performance Consistency
About Abbott Laboratories
Visit Website ↗Abbott Laboratories is a global healthcare company that is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The company's products include a range of medical devices, diagnostic products, nutritional products and branded generic pharmaceuticals.
Key Business Segments
Established Pharmaceutical Products
This segment includes a broad line of branded generic pharmaceuticals manufactured and marketed and sold outside the United States.
Diagnostic Products
This segment includes a range of diagnostic systems and tests for blood screening, clinical chemistry, and immunodiagnostics.
Nutritional Products
This segment includes a range of adult and pediatric nutritional products.
Medical Devices
This segment includes a range of medical devices for cardiac and vascular diseases, diabetes care, and neuromodulation.
Key Innovations
- ✓Pioneered the development of the first HIV blood-screening test.
- ✓Introduced the first-ever drug-eluting stent to treat coronary artery disease.
- ✓Developed the FreeStyle Libre, a revolutionary continuous glucose monitoring system.
Historical Milestones
Dr. Wallace C. Abbott, a Chicago physician, starts making his own scientifically formulated medicines.
Abbott's first public offering of stock.
Abbott acquires M&R Dietetic Laboratories, the maker of Similac infant formula.
Abbott separates its research-based pharmaceutical business, which becomes AbbVie.
Abbott acquires St. Jude Medical and Alere Inc., significantly expanding its medical device and diagnostics businesses.